Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
Mã chứng khoánCBUS
Tên công tyCibus Inc
Ngày IPOJul 20, 2017
Giám đốc điều hànhDr. Peter Ronald Beetham, Ph.D.
Số lượng nhân viên157
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhJul 20
Địa chỉ6455 Nancy Ridge Drive
Thành phốSAN DIEGO
Sàn giao dịch chứng khoánNASDAQ Capital Market Consolidated
Quốc giaUnited States of America
Mã bưu điện92121
Điện thoại18584500008
Trang webhttps://www.cibus.com/
Mã chứng khoánCBUS
Ngày IPOJul 20, 2017
Giám đốc điều hànhDr. Peter Ronald Beetham, Ph.D.
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu